Imeik Technology Development Co.,Ltd. (SHE:300896)

China flag China · Delayed Price · Currency is CNY
116.42
-1.92 (-1.62%)
Apr 28, 2026, 3:08 PM CST
-34.30%
Market Cap 35.09B
Revenue (ttm) 2.42B
Net Income (ttm) 1.15B
Shares Out 301.43M
EPS (ttm) 3.80
PE Ratio 30.64
Forward PE 26.28
Dividend 1.60 (1.35%)
Ex-Dividend Date Apr 29, 2026
Volume 2,699,268
Average Volume 2,437,461
Open 116.51
Previous Close 118.34
Day's Range 116.03 - 119.68
52-Week Range 112.30 - 202.88
Beta 0.97
RSI 42.08
Earnings Date Apr 23, 2026

About SHE:300896

Imeik Technology Development Co.,Ltd. engages in the research and development, and transformation of biomedical materials and biopharmaceutical products in China. The company offers aesthetic medicine products, such as cross-linked sodium hyaluronate gel with PLLA-b-PEG microsphere; poly facial implant thread; medical sodium hyaluronate-hydroxypropyl methylcellulose gel; sodium hyaluronate composite solution for injection; modified sodium hyaluronate gel for injection; medical PVA gel ball-sodium hyaluronate-hydroxypropyl methylcellulose gel; a... [Read more]

Sector Healthcare
Founded 2004
Employees 1,458
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300896
Full Company Profile

Financial Performance

In 2025, SHE:300896's revenue was 2.45 billion, a decrease of -18.94% compared to the previous year's 3.03 billion. Earnings were 1.29 billion, a decrease of -34.05%.

Financial Statements

News

There is no news available yet.